Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Analysis of apolipoprotein A5, C3 and plasma triglyceride concentrations in genetically engineered mice

Journal Article · · Arteriosclerosis, Thrombosis, and Vascular Biology
To address the relationship between the apolipoprotein A5 and C3 genes, we generated independent lines of mice that either over-expressed or completely lacked both genes. We report both lines display normal triglyceride concentrations compared to over-expression or deletion of either gene alone. Together, these data support that APOA5 and APOC3 independently influence plasma triglyceride concentrations but in an opposing manner.
Research Organization:
Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA (US)
Sponsoring Organization:
US Department of Energy; National Institutes of Health National Heart Lung and Blood Institute Grants HL66681 and HL071954A,American Heart Association Postdoctoral Fellowship (US)
DOE Contract Number:
AC03-76SF00098
OSTI ID:
838068
Report Number(s):
LBNL--55257
Journal Information:
Arteriosclerosis, Thrombosis, and Vascular Biology, Journal Name: Arteriosclerosis, Thrombosis, and Vascular Biology Journal Issue: 7 Vol. 24
Country of Publication:
United States
Language:
English

Similar Records

Independent effects of apolipoprotein AV and apolipoprotein CIII on plasma triglyceride concentrations
Journal Article · Fri Aug 15 00:00:00 EDT 2003 · Arteriosclerosis, Thrombosis & Vascular Biology · OSTI ID:834631

Apolipoprotein A5: A newly identified gene impacting plasmatriglyceride levels in humans and mice
Journal Article · Sun Sep 15 00:00:00 EDT 2002 · Arteriosclerosis, Thrombosis and Vascular Biology(ATVB) · OSTI ID:894967

Two independent apolipoprotein a5 Haplotypes influence human plasma triglyceride levels
Journal Article · Mon Sep 16 00:00:00 EDT 2002 · Human Molecular Genetics · OSTI ID:822955